Clinical Handbook of Psychotropic Drugs for Children and Adolescents, 5th Edition (PDF)

30 $

Delivery time: Maximum to 1 hours

Format : Publisher PDF

File Size : 6.5 MB

The Clinical Handbook of Psychotropic Drugs for Children and Adolescents provides concise and accurate information on psychotropic drugs specific to children and adolescents, including comparison charts and tables for an easy-to-read and quick overview of treatment options. It is a must-have reference for mental health professionals working with young patients and includes information on new medications and formulations. The 5th edition, which will be released on May 8, 2023, has added new chapters and revised existing ones. The book is spiral-bound and has 438 pages.

Category: Medical Book

Description

Clinical Handbook of Psychotropic Drugs for Children and Adolescents, 5th Edition (PDF Book)

By Dean Elbe, Tyler R. Black, Ian R. McGrane, Sabina Choi

Comprehensive and accurate information regarding psychotropic drugs for children and adolescents.

– Precise and current

– Adverse effects only occur in children and adolescents.

– Charts and tables facilitate decision making.

Icons and colorful images

The Clinical Handbook of Psychotropic Medicines for Children and Adolescents has become a common reference and practical tool for psychiatrists, pediatricians, psychologists, physicians, pharmacists, nurses, and other healthcare professionals.

• Frequent new updates regarding special, easy-to-read graphs and tables (dosages, effects, pharmacokinetics, interactions…) that provide a quick understanding of treatment options

• succinct, listed information regarding all classes of medication, including on-label and off-label uses, side effects, interactions, pharmacodynamics, nursing implications, and more – all of the information you need to know about each class of drug is listed here.

• Future planned interactions and effects that are summarized in a comparison chart.

• With easily identificable icons and which are colorful and full of information, it allows you to find what you want quickly.

Patients and caregivers should be aware of the information that is clearly written on the sheet, this information can be printed as a PDF file.

This book is essential for all mental health professionals that work with children and adolescents, these individuals need a contemporary, simple to use, and comprehensive description of all of the most important information regarding psychotropic drugs.

New this year:

New sections on the Prescribing Safely and Ethically to Children and Adolescents, Pharmacogenetic Information regarding Common Psychotropic Drugs, and Aggression Management in Children and Adolescents

• New terms based on Neuroscience are incorporated into the Product Availability tables.

• Antipsychotic-induced extrapyramidal side effects (EPSE) have been completely revised plus a new section on the monitoring of EPSE.

• Anxiolytics section on the buspirone and benzodiazepine comparison table updated

• Mood Stabilizers chapter extensively revised

Natural Health Products were completely revised.

New treatments that are still in the developmental stages of being approved, including evidence for cannabidiol and folinic acid regarding the spectrum of autism, and ketamine regarding mood disorders.

New agents include: deutetrabenazine, ethopropazine, lemborexant, and so on.

New formulations and trademark names include: Austedo, Caplyta, Dayvigo, Drizalma Sprinkle, Elepsia XR, Eprontia, Evekeo ODT, Gocovri, Hetlioz LQ, Ingrezza, Invega Hafyera, Jornay PM, Loreev XR, Lybalvi, Osmolex ER, Oxtellar XR, Parsitan, Perseris, Qelbree, Qudexy XR, Secuado, Spritam, Tyrvaya, Valtoco.